Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-033876
Filing Date
2026-05-12
Accepted
2026-05-12 07:17:01
Documents
52
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sionna-20260331.htm   iXBRL 10-Q 1231362
2 EX-31.1 sionna-10xkxex311certifica.htm EX-31.1 10687
3 EX-31.2 sionna-10xkxex312certifica.htm EX-31.2 10864
4 EX-32.1 sionna-10xkxex321certifica.htm EX-32.1 9278
  Complete submission text file 0001628280-26-033876.txt   4755279

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sionna-20260331.xsd EX-101.SCH 25727
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sionna-20260331_cal.xml EX-101.CAL 53005
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sionna-20260331_def.xml EX-101.DEF 85225
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sionna-20260331_lab.xml EX-101.LAB 438080
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sionna-20260331_pre.xml EX-101.PRE 269741
56 EXTRACTED XBRL INSTANCE DOCUMENT sionna-20260331_htm.xml XML 509117
Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Filer) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42504 | Film No.: 26965863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)